J. Plantier

Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency

C. Négrier, Y. Dargaud, H. Boukerche, 2010, Journal of thrombosis and haemostasis : JTH.

Two novel mutations in EGF‐like domains of human factor IX dramatically impair intracellular processing and secretion

C. Négrier, C. Vinciguerra, N. Enjolras, 2004, Journal of thrombosis and haemostasis : JTH.

A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF‐binding site distant from its epitope

B. Atanasov, S. Kaveri, S. Lacroix-Desmazes, 2010, Journal of thrombosis and haemostasis : JTH.

A Factor VIII Minigene Comprising the Truncated Intron I of Factor IX Highly Improves the In Vitro Production of Factor VIII

C. Négrier, N. Enjolras, J. Plantier, 2001, Thrombosis and Haemostasis.

Expression of Coagulation Factor IX in a Haematopoietic Cell Line

C. Négrier, M. Leboeuf, G. Uzan, 2002, Thrombosis and Haemostasis.

The P‐selectin cytoplasmic domain directs the cellular storage of a recombinant chimeric factor IX

C. Négrier, E. Cramer, J. Massé, 2003, Journal of thrombosis and haemostasis : JTH.

The Three In-frame ATG, Clustered in the Translation Initiation Sequence of Human Factor IX Gene, Are Required for an Optimal Protein Production

C. Négrier, M. Maurice, N. Enjolras, 1999, Thrombosis and Haemostasis.

A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF‐binding site distant from its epitope

S. Kaveri, S. Lacroix-Desmazes, J. Dimitrov, 2010, Journal of thrombosis and haemostasis : JTH.

A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope J. D. DIMITROV,* 1 L. T. ROUMENINA,* 1 J.-L. PLANTIER,§ S. ANDRE,* D. SABOULARD,-

S. Kaveri, S. Lacroix-Desmazes, J. Dimitrov, 2010 .